Recently published results from the ESMO Women for Oncology Monitoring and Authorship Studies has revealed that "women continue to be underrepresented in leadership positions despite making up an increasing proportion of the oncology workforce." Data collected from 2017-2019 from several worldwide oncology societies scrutinized the number of women as board members or presidents of oncology organizations/societies, as well as representation at cancer conferences. The data has revealed 37% of speaker at oncology congresses are women, while 36% of females are presented on the boards of professional organizations. In addition, 37-41% of women are lead authors in cancer publications.
To read more about this study, click here.
Studies mentioned:
- A.S. Berghoff, C. Sessa, J.C.-H. Yang, Z. Tsourti, J. Tsang, J. Tabernero, S. Peters, H. Linardou, A. Letsch, J. Haanen, E. Garralda, M.C. Garassino, A.J.S. Furness, E. Felip, G. Dimopoulou, U. Dafni, S.P. Choo, S. Banerjee, J. Bajpai, A.A. Adjei and P. Garrido. Female leadership in oncology—has progress stalled? Data from the ESMO W4O authorship and monitoring studies. https://doi.org/10.1016/j.esmoop.2021.100281
- E. Hofstädter-Thalmann, U. Dafni, T. Allen, D. Arnold, S. Banerjee, G. Curigliano, E. Garralda, M.C. Garassino, J. Haanen, C. Robert, C. Sessa, Z. Tsourti, P. Zygoura, S. Peters. Report on the status of women occupying leadership roles in oncology. https://doi.org/10.1136/esmoopen-2018-000423
No comments:
Post a Comment